304 related articles for article (PubMed ID: 30784899)
21. Meta-analysis of circulating adiponectin, leptin, and resistin levels in systemic sclerosis.
Lee YH; Song GG
Z Rheumatol; 2017 Nov; 76(9):789-797. PubMed ID: 27515182
[TBL] [Abstract][Full Text] [Related]
22. BAL cytokine profile in different interstitial lung diseases: a focus on systemic sclerosis.
Meloni F; Caporali R; Marone Bianco A; Paschetto E; Morosini M; Fietta AM; Patrizio V; Bobbio-Pallavicini F; Pozzi E; Montecucco C
Sarcoidosis Vasc Diffuse Lung Dis; 2004 Jun; 21(2):111-8. PubMed ID: 15281432
[TBL] [Abstract][Full Text] [Related]
23. Epoprostenol up-regulates serum adiponectin level in patients with systemic sclerosis: therapeutic implications.
Stochmal A; Czuwara J; Zaremba M; Rudnicka L
Arch Dermatol Res; 2021 Nov; 313(9):783-791. PubMed ID: 33433715
[TBL] [Abstract][Full Text] [Related]
24. Metabolic syndrome and adipokine levels in systemic lupus erythematosus and systemic sclerosis.
Gigante A; Iannazzo F; Navarini L; Sgariglia MC; Margiotta DPE; Vaiarello V; Foti F; Afeltra A; Cianci R; Rosato E
Clin Rheumatol; 2021 Oct; 40(10):4253-4258. PubMed ID: 33839992
[TBL] [Abstract][Full Text] [Related]
25. Elevated level of Galectin-1 in bronchoalveolar lavage of patients with idiopathic pulmonary fibrosis.
Bennett D; Bargagli E; Bianchi N; Landi C; Fossi A; Fui A; Sestini P; Refini RM; Rottoli P
Respir Physiol Neurobiol; 2020 Feb; 273():103323. PubMed ID: 31678459
[TBL] [Abstract][Full Text] [Related]
26. Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis.
Stock CJ; Sato H; Fonseca C; Banya WA; Molyneaux PL; Adamali H; Russell AM; Denton CP; Abraham DJ; Hansell DM; Nicholson AG; Maher TM; Wells AU; Lindahl GE; Renzoni EA
Thorax; 2013 May; 68(5):436-41. PubMed ID: 23321605
[TBL] [Abstract][Full Text] [Related]
27. Adipocytokine levels in gastric cancer patients: resistin and visfatin as biomarkers of gastric cancer.
Nakajima TE; Yamada Y; Hamano T; Furuta K; Gotoda T; Katai H; Kato K; Hamaguchi T; Shimada Y
J Gastroenterol; 2009; 44(7):685-90. PubMed ID: 19430715
[TBL] [Abstract][Full Text] [Related]
28. CCL18 as an indicator of pulmonary fibrotic activity in idiopathic interstitial pneumonias and systemic sclerosis.
Prasse A; Pechkovsky DV; Toews GB; Schäfer M; Eggeling S; Ludwig C; Germann M; Kollert F; Zissel G; Müller-Quernheim J
Arthritis Rheum; 2007 May; 56(5):1685-93. PubMed ID: 17469163
[TBL] [Abstract][Full Text] [Related]
29. Resistin and visfatin: regulators of insulin sensitivity, inflammation and immunity.
Stofkova A
Endocr Regul; 2010 Jan; 44(1):25-36. PubMed ID: 20151765
[TBL] [Abstract][Full Text] [Related]
30. Measurement of salivary resistin, visfatin and adiponectin levels.
Mamali I; Roupas ND; Armeni AK; Theodoropoulou A; Markou KB; Georgopoulos NA
Peptides; 2012 Jan; 33(1):120-4. PubMed ID: 22108712
[TBL] [Abstract][Full Text] [Related]
31. Serum levels of visfatin, resistin and adiponectin in patients with psoriatic arthritis and associations with disease severity.
Dikbas O; Tosun M; Bes C; Tonuk SB; Aksehirli OY; Soy M
Int J Rheum Dis; 2016 Jul; 19(7):672-7. PubMed ID: 25196858
[TBL] [Abstract][Full Text] [Related]
32. The Role of Adipose Tissue and Adipokines in Sepsis: Inflammatory and Metabolic Considerations, and the Obesity Paradox.
Karampela I; Christodoulatos GS; Dalamaga M
Curr Obes Rep; 2019 Dec; 8(4):434-457. PubMed ID: 31637623
[TBL] [Abstract][Full Text] [Related]
33. In the Pursuit of Metabolic Markers of Systemic Sclerosis-Plasma Adiponectin and Omentin-1 in Monitoring the Course of the Disease.
Dopytalska K; Kalisz M; Litwiniuk A; Walecka I; Bik W; Baranowska-Bik A
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373131
[TBL] [Abstract][Full Text] [Related]
34. Molecular aspects of adipokine-bone interactions.
Magni P; Dozio E; Galliera E; Ruscica M; Corsi MM
Curr Mol Med; 2010 Aug; 10(6):522-32. PubMed ID: 20642443
[TBL] [Abstract][Full Text] [Related]
35. Genetic Association of Circulating Adipokines with Risk of Idiopathic Pulmonary Fibrosis: A Two-Sample Mendelian Randomization Study.
Huang D; Gong L; Wu Z; Shi Y; Liang Z
Lung; 2023 Aug; 201(4):355-362. PubMed ID: 37530803
[TBL] [Abstract][Full Text] [Related]
36. The Role of Adipokines in Breast Cancer: Current Evidence and Perspectives.
Christodoulatos GS; Spyrou N; Kadillari J; Psallida S; Dalamaga M
Curr Obes Rep; 2019 Dec; 8(4):413-433. PubMed ID: 31637624
[TBL] [Abstract][Full Text] [Related]
37. Plasma visfatin levels and gene expression in morbidly obese women with associated fatty liver disease.
Auguet T; Terra X; Porras JA; Orellana-Gavaldà JM; Martinez S; Aguilar C; Lucas A; Pellitero S; Hernández M; Del Castillo D; Richart C
Clin Biochem; 2013 Feb; 46(3):202-8. PubMed ID: 23174488
[TBL] [Abstract][Full Text] [Related]
38. Splanchnic concentrations and postprandial release of visceral adipokines.
Wiest R; Moleda L; Farkas S; Scherer M; Kopp A; Wönckhaus U; Büchler C; Schölmerich J; Schäffler A
Metabolism; 2010 May; 59(5):664-70. PubMed ID: 19913846
[TBL] [Abstract][Full Text] [Related]
39. Adipokines: A Possible Contribution to Vascular and Bone Remodeling in Idiopathic Pulmonary Arterial Hypertension.
Kochetkova EA; Ugai LG; Maistrovskaia YV; Nevzorova VA
Calcif Tissue Int; 2017 Apr; 100(4):325-331. PubMed ID: 28039519
[TBL] [Abstract][Full Text] [Related]
40. The influence of intensive physical training on salivary adipokine levels in Elite Rhythmic Gymnasts.
Roupas ND; Mamali I; Armeni AK; Markantes GK; Theodoropoulou A; Alexandrides TK; Leglise M; Markou KB; Georgopoulos NA
Horm Metab Res; 2012 Dec; 44(13):980-6. PubMed ID: 22864904
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
